返回 Agenda
Session Chair(s)
Vikki D. Brown, DrMed
Medical Director Post Approval and Strategic Services
INC Research, United States
Learning Objective : explain the difference between randomized controlled and observational clinical trials understand the importance of the real-world setting to demonstrate clinical effectiveness describe the impact of economic outcomes to clinical decision making (payer perspective)
Speaker(s)
Real-world clinical studies - from the bench to the clinic to economic feasibility
Felix Frueh, PHD
Opus Three LLC, United States
Executive Partner
Data at the Heart of Clinical Trials – The key to successful Health Outcomes Research
Wolfgang Summa, PHD, MS
ERT, United States
Vice President Operations, invivodata, Inc. , USA
Best use of late-phase clinical trials: how to meet health care research purposes and secure drug effectiveness claims?
Markus Hartmann, PHD, RAC
Merck KGaA, Germany
Head of Data Value Office-R&D Digital Data Transformation